U.S. Gas Utilities Stock News

Investor anxiety over a potential AI bubble has dragged Zeta Global Holdings (ZETA) into the latest tech selloff, as warnings about shrinking margins push traders to rotate from high growth software names into steadier corners of the market. See our latest analysis for Zeta Global Holdings. Even with the recent AI jitters weighing on sentiment, Zeta’s latest close at $17.99 leaves it with a mildly negative year to date share price return. Its three year total shareholder return of 119.12...

Celldex Therapeutics (CLDX) has been back on traders radar after a recent bump in the share price, leaving many investors wondering whether this clinical stage biotech is quietly setting up for its next move. See our latest analysis for Celldex Therapeutics. With the latest uptick to about $25.60, Celldex’s 30 day share price return of 2.73 percent and modest 90 day gain hint at cautiously improving momentum, even as the 3 year total shareholder return of negative 41.96 percent reminds...

Flowserve (FLS) has quietly rewarded patient shareholders, with the stock up about 24% over the past year and roughly 25% in the past 3 months, outpacing many industrial peers. See our latest analysis for Flowserve. With the share price now around $71, Flowserve has built steady momentum, with a strong 90 day share price return and a standout three year total shareholder return that point to rising confidence in its long term prospects. If Flowserve’s run has you rethinking your watchlist,...

The Trade Desk (TTD) just announced a small round of layoffs, trimming less than 1% of its staff, a follow up to last year's larger restructuring as the ad tech environment continues to tighten. See our latest analysis for Trade Desk. Those small cuts sit against a much tougher backdrop, with the 1 year share price return down around 70 percent as investors reassess growth and competitive risks, even though Trade Desk is still growing revenue and margins. As a result, sentiment looks more...

Wondering if Match Group at around $33 is a hidden bargain or a value trap in the making? This article will walk you through the numbers in plain language so you can decide for yourself. Despite a modest 4.8% gain over the last 30 days and being up 1.3% year to date, the stock is still roughly flat over the past year and sits far below its 5 year highs. That keeps both value hunters and skeptics interested. Recent headlines have focused on Match Group sharpening its product strategy and...

Leidos Holdings has appointed Theodore "Ted" Tanner Jr. as its new chief technology officer, effective January 5, 2026, bringing experience from BigBear.ai, IBM Watson Health, and several AI-focused startups, while outgoing CTO Jim Carlini will remain as a senior advisor on national security. Tanner’s background in artificial intelligence, machine learning, and cloud technologies, underscored by 18 U.S. patents and work across defense and healthcare, signals a deeper push by Leidos into...

KB Home (KBH) has wrapped up FY 2025 with fourth quarter revenue of about $1.7 billion and basic EPS of roughly $1.59, setting a clear marker for how its homebuilding cycle is playing out amid softer profitability trends over the past year. The company has seen quarterly revenue ease from around $2.0 billion and EPS of about $2.59 in Q4 2024 to $1.7 billion and $1.59 in Q4 2025, while trailing net profit margins have compressed. This puts the spotlight firmly on how sustainable its current...

Iovance Biotherapeutics (IOVA) is back in the spotlight after fresh FDA related progress on its lifileucel cancer therapy and a Phase 2 melanoma update. These developments are reshaping how investors are sizing up the stock. See our latest analysis for Iovance Biotherapeutics. Those FDA tailwinds and trial updates have sparked a sharp turnaround in sentiment. The latest share price of $2.48 is supported by a 7 day share price return of 12.73 percent and a 90 day share price return of 20.98...

United Therapeutics (UTHR) has been drawing fresh attention after progress in its xenotransplantation studies and stronger financial results, a combination that is quietly reshaping how many investors frame the long term story. See our latest analysis for United Therapeutics. Those xenotransplantation milestones and solid earnings have coincided with a powerful move in the stock, with a year to date share price return above 40 percent and five year total shareholder return above 200 percent,...

On December 10, 2025, Honeywell International announced that former PepsiCo Chair and CEO Indra Nooyi will join its board as an independent director effective January 1, 2026, bringing extensive global leadership and governance experience. Her simultaneous board roles at Amazon and Philips suggest Honeywell is prioritizing seasoned oversight as it reshapes its portfolio and governance ahead of major business separations. We’ll now examine how Indra Nooyi’s appointment and Honeywell’s broader...

Setting the scene for Luda Technology Group's latest results Luda Technology Group (LUD) opened H1 2025 with trailing 12 month revenue of about $37.1 million and basic EPS of roughly negative $0.08, reflecting unprofitable operations over the period. The company has seen reported half year revenue move from $26.3 million in H2 2023 to $24.9 million in H1 2024, then down to $19.9 million in H2 2024, while basic EPS shifted from $0.04 to $0.05 before slipping to negative $0.07 alongside net...

Northrop Grumman (NOC) has quietly kept investors interested this year, with the stock up about 21% year to date and roughly 23% over the past year, outpacing many defense peers. See our latest analysis for Northrop Grumman. At a share price of $568.46, Northrop Grumman has seen steady upward momentum this year, with a strong year to date share price return contributing to a robust one year total shareholder return as investors warm to its growth pipeline and perceived resilience. If Northrop...

Klarna Group (KLAR) shares have been drifting after a weak past 3 months, and that slide now has investors asking whether the company’s improving growth profile justifies stepping in at current levels. See our latest analysis for Klarna Group. The latest $30.78 share price may look subdued after a sharp 90 day share price return of negative 28.44 percent and weak year to date performance, but that pullback follows brisk revenue and earnings momentum that has investors reassessing both growth...

If you have been wondering whether Carnival Corporation and stock is still a bargain after its rebound, you are not alone. This article will unpack what the current share price really implies about future cruises and cash flows. The stock has climbed 12.7% over the last week, 19.3% over the past month, and is now up 24.4% year to date. This builds on a 298.5% gain over three years that has significantly changed how investors view its risk and recovery story. Recent headlines have focused on...

If you have been wondering whether Medtronic is still a buy at around $98 a share, you are not alone. This article is designed to unpack what that price really implies about the company’s value. The stock is down about 1.2% over the last week and 1.7% over the last month, but it is still up 22.9% year to date and 25.7% over the past year, which signals a meaningful shift in how the market is viewing its long term prospects. Recent headlines have focused on Medtronic’s push to streamline its...

Expeditors International of Washington (EXPD) has quietly delivered strong gains this year, with the stock up about 39% year to date and roughly 27% over the past 3 months, outpacing many logistics peers. See our latest analysis for Expeditors International of Washington. The latest move to around $152 per share caps a steady run, with a near 10% 1 month share price return adding to an already strong year of building momentum. If you want to see what other logistics-like trends are playing...

Lamb Weston Holdings (LW) has just posted Q2 2026 results with revenue of about $1.6 billion and basic EPS of $0.45, alongside net income of $62.1 million that gives investors a fresh read on how the frozen potato giant is navigating a tougher margin backdrop. The company has seen quarterly revenue move around the $1.5 billion to $1.7 billion mark over the past six periods, while basic EPS has ranged from a loss of $0.25 in Q2 2025 to a high of $1.03. This sets up the latest print as part of...

Transocean (RIG) has quietly drifted lower over the past week, but the bigger story is how this offshore driller’s longer term recovery case stacks up against a still choppy earnings backdrop. See our latest analysis for Transocean. At around $3.97 a share, Transocean’s recent 7 day share price return of negative 3.87 percent contrasts with a stronger 90 day share price return of 19.58 percent and a 1 year total shareholder return of 12.46 percent. This suggests momentum has cooled, while the...

If you are wondering whether Rigetti Computing is still worth considering after its huge run, or if the easy money has already been made, this article will walk through the numbers in plain English. The stock has cooled off recently, with shares down 8.0% over the last week and 6.7% over the last month. Even so, they are still up 18.8% year to date, an eye catching 153.6% over the past year, and a massive 2774.4% over three years. Behind those swings, Rigetti has remained in the spotlight as...

Twenty One Capital (XXI) has quietly become a way to play the Bitcoin balance-sheet trend, with its shares swinging sharply this past 3 months even as its one year return remains slightly positive. See our latest analysis for Twenty One Capital. That volatility has cut the 90 day share price return to a steep loss, even though the year to date share price return is still positive and the one year total shareholder return sits just under 9 percent. This suggests that momentum is fading but not...

Invesco Mortgage Capital (IVR) just gave income investors something new to chew on, raising its common stock dividend to 0.36 dollars a share and shifting from quarterly to monthly payouts starting January. See our latest analysis for Invesco Mortgage Capital. The market seems to like this move already, with a 1 month share price return of just over 16 percent feeding into a roughly 27 percent 1 year total shareholder return. However, the 5 year total shareholder return still sits deeply...

Whether you are wondering if Pilgrim's Pride at around $39 a share is still a bargain or if the easy money has already been made, this breakdown is designed to give you a clear, valuation focused view of where the stock currently stands. The share price has slipped about 1.3% over the last week but is still up 4.9% over the past month. When you zoom out to 3 and 5 years, the stock has delivered gains of 95.6% and 140.6% respectively, even though it is roughly flat over the last year and down...

Huntington Bancshares (HBAN) has quietly put together a solid run, with shares up around 15% over the past month and roughly 9% this year. The stock has outpaced many regional banking peers. See our latest analysis for Huntington Bancshares. Trading around $17.69, Huntington Bancshares is showing renewed momentum, with a strong 30 day share price return feeding into a solid year to date climb, while its multiyear total shareholder returns point to a steadily compounding story rather than a...

Federal Home Loan Mortgage (FMCC) is back in focus after Freddie Mac tapped veteran adviser Kenny M. Smith as its new CEO and board member, a leadership shift that naturally invites fresh views on valuation. See our latest analysis for Federal Home Loan Mortgage. The leadership shake up appears to be landing well with investors, with a 1 day share price return of 2.36 percent at 10.39 dollars and strong longer term total shareholder returns suggesting momentum is still broadly intact, despite...